JP2022524435A5 - - Google Patents
Info
- Publication number
- JP2022524435A5 JP2022524435A5 JP2021554697A JP2021554697A JP2022524435A5 JP 2022524435 A5 JP2022524435 A5 JP 2022524435A5 JP 2021554697 A JP2021554697 A JP 2021554697A JP 2021554697 A JP2021554697 A JP 2021554697A JP 2022524435 A5 JP2022524435 A5 JP 2022524435A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- induced
- modifications
- target site
- donor dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024116841A JP2024133347A (ja) | 2019-03-11 | 2024-07-22 | Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962816836P | 2019-03-11 | 2019-03-11 | |
| US62/816,836 | 2019-03-11 | ||
| US201962901735P | 2019-09-17 | 2019-09-17 | |
| US62/901,735 | 2019-09-17 | ||
| PCT/US2020/022056 WO2020185867A1 (en) | 2019-03-11 | 2020-03-11 | Improved process for integration of dna constructs using rna-guided endonucleases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024116841A Division JP2024133347A (ja) | 2019-03-11 | 2024-07-22 | Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022524435A JP2022524435A (ja) | 2022-05-02 |
| JP2022524435A5 true JP2022524435A5 (cg-RX-API-DMAC7.html) | 2023-03-15 |
Family
ID=70190148
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554697A Pending JP2022524435A (ja) | 2019-03-11 | 2020-03-11 | Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上 |
| JP2024116841A Pending JP2024133347A (ja) | 2019-03-11 | 2024-07-22 | Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024116841A Pending JP2024133347A (ja) | 2019-03-11 | 2024-07-22 | Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220145333A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3938510A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022524435A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210149734A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113825834A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020239050A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3133226A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL286244A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021010938A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202109972QA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020185867A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4139345A1 (en) | 2020-04-24 | 2023-03-01 | Sorrento Therapeutics, Inc. | Memory dimeric antigen receptors |
| WO2022015956A1 (en) | 2020-07-15 | 2022-01-20 | Sorrento Therapeutics, Inc. | Improved process for dna integration using rna-guided endonucleases |
| WO2022061115A1 (en) * | 2020-09-18 | 2022-03-24 | Vor Biopharma Inc. | Compositions and methods for cd7 modification |
| JP7877351B2 (ja) * | 2021-03-19 | 2026-06-22 | メタゲノミ セラピューティクス,インク. | Cas酵素を用いたマルチプレックス編集 |
| US20240182890A1 (en) * | 2021-04-07 | 2024-06-06 | Astrazeneca Ab | Compositions and methods for site-specific modification |
| CA3223311A1 (en) * | 2021-06-18 | 2022-12-22 | Andrea BARGHETTI | Compositions and methods for targeting, editing or modifying human genes |
| WO2023097236A1 (en) * | 2021-11-24 | 2023-06-01 | The Rockefeller University | Compositions and methods for generating immunoglobulin knock-in mice |
| CN115851591A (zh) * | 2022-11-30 | 2023-03-28 | 山东博群生物技术有限公司 | 细胞因子刺激剂及诱导淋巴细胞产生细胞因子的方法 |
| WO2026020171A2 (en) | 2024-07-19 | 2026-01-22 | Aera Therapeutics, Inc. | Chimeric antigen receptor constructs |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
| US5489677A (en) | 1990-07-27 | 1996-02-06 | Isis Pharmaceuticals, Inc. | Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms |
| US6555674B2 (en) | 2000-08-09 | 2003-04-29 | Nsgene A/S | JeT promoter |
| CA2720903C (en) * | 2008-04-14 | 2019-01-15 | Sangamo Biosciences, Inc. | Linear donor constructs for targeted integration |
| ES2728782T3 (es) | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| CA2932439A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute, Inc. | Crispr-cas systems and methods for altering expression of gene products, structural information and inducible modular cas enzymes |
| CN113930455A (zh) * | 2014-10-09 | 2022-01-14 | 生命技术公司 | Crispr寡核苷酸和基因剪辑 |
| CA2986310A1 (en) * | 2015-05-11 | 2016-11-17 | Editas Medicine, Inc. | Optimized crispr/cas9 systems and methods for gene editing in stem cells |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| JP7011590B2 (ja) * | 2015-10-12 | 2022-02-10 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 細胞内での遺伝子組換えおよび相同組換えの増加のための保護dna鋳型および使用方法 |
| JP2019532644A (ja) | 2016-09-30 | 2019-11-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Rna誘導型核酸修飾酵素及びその使用方法 |
| KR20190130608A (ko) * | 2017-03-22 | 2019-11-22 | 노파르티스 아게 | 면역종양학을 위한 조성물 및 방법 |
| MY200418A (en) * | 2017-06-15 | 2023-12-25 | Univ California | Targeted non-viral dna insertions |
| JP2020530997A (ja) * | 2017-08-08 | 2020-11-05 | サンガモ セラピューティクス, インコーポレイテッド | キメラ抗原受容体媒介性細胞標的化 |
| SG11202008568WA (en) | 2018-03-09 | 2020-10-29 | Sorrento Therapeutics Inc | Dimeric antigen receptors (dar) |
-
2020
- 2020-03-11 EP EP20717424.4A patent/EP3938510A1/en not_active Withdrawn
- 2020-03-11 US US17/438,039 patent/US20220145333A1/en not_active Abandoned
- 2020-03-11 JP JP2021554697A patent/JP2022524435A/ja active Pending
- 2020-03-11 MX MX2021010938A patent/MX2021010938A/es unknown
- 2020-03-11 KR KR1020217032629A patent/KR20210149734A/ko not_active Withdrawn
- 2020-03-11 SG SG11202109972Q patent/SG11202109972QA/en unknown
- 2020-03-11 AU AU2020239050A patent/AU2020239050A1/en not_active Abandoned
- 2020-03-11 CN CN202080035087.XA patent/CN113825834A/zh active Pending
- 2020-03-11 CA CA3133226A patent/CA3133226A1/en active Pending
- 2020-03-11 WO PCT/US2020/022056 patent/WO2020185867A1/en not_active Ceased
-
2021
- 2021-09-09 IL IL286244A patent/IL286244A/en unknown
-
2024
- 2024-07-22 JP JP2024116841A patent/JP2024133347A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521787A5 (cg-RX-API-DMAC7.html) | ||
| JP2024174943A5 (cg-RX-API-DMAC7.html) | ||
| US11884915B2 (en) | Guide RNAs with chemical modification for prime editing | |
| JP2022523302A (ja) | アッシャー症候群の処置のためのrna編集オリゴヌクレオチド | |
| RU2017130143A (ru) | Гибридные днк/рнк-полинукдеотиды crispr и способы | |
| JP2018138054A5 (cg-RX-API-DMAC7.html) | ||
| US20120015821A1 (en) | Methods of Generating Gene Specific Libraries | |
| CN107787367A (zh) | 用于crispr/cas介导的基因调控的化学修饰的引导rna | |
| JP2023504264A5 (cg-RX-API-DMAC7.html) | ||
| EP3277816A1 (en) | Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy and becker muscular dystrophy | |
| JP2020524998A5 (cg-RX-API-DMAC7.html) | ||
| EP3344771A1 (en) | Compounds and methods for crispr/cas-based genome editing by homologous recombination | |
| CA2968336A1 (en) | Construct for site directed editing of an adenosine nucleotide in target rna | |
| WO2016094845A3 (en) | Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides | |
| CA3025523A1 (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules | |
| CN102203273A (zh) | 生成基因特异性的文库的方法 | |
| WO2015089053A1 (en) | Long nucleic acid sequences containing variable regions | |
| RU2020100919A (ru) | СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ | |
| CA3133226A1 (en) | Improved process for integration of dna constructs using rna-guided endonucleases | |
| JP2024533448A (ja) | 化学修飾を有するガイドrnaを使用する方法 | |
| JP7762651B2 (ja) | 修飾二重鎖ドナー鋳型 | |
| Layden et al. | Alternate trans splicing in Trypanosoma equiperdum: implications for splice site selection | |
| US12522857B2 (en) | Compositions and methods of targeted nucleic acid enrichment by loop adapter protection and exonuclease digestion | |
| WO2023015205A2 (en) | Compositions and methods for improved gene editing | |
| Moss | History and development of molecular biology |